Clinical trial

A Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on…

NCT03625531 · Hongxia Ma, Other · Unknown status

Key facts

NCT number NCT03625531
Title A Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth in Women With PCOS
Official title A Multicenter Randomized Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth for Infertility in Women With Polycystic Ovary Syndrome
Lead sponsor Hongxia Ma, Other
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Polycystic Ovary Syndrome
Intervention type Drug, Other
Interventions Acupuncture, Letrozole, Placebo letrozole
Enrollment 1,100
Start date Aug 13, 2018
Primary completion Oct 31, 2023
Completion Jan 31, 2024
First posted Aug 10, 2018
Last update posted Apr 5, 2022
Countries China

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies